Application of Clinical Pathway Management Model in the Nursing of Patients with Liver Cirrhosis Complicated with Upper Gastrointestinal Bleeding

LU Yunjian; XU Xiaomin

doi:10.14033/j.cnki.cfmr.2025.07.020

Abstract：Objective:To study the effect of clinical pathway management model for patients with liver cirrhosis complicated with upper gastrointestinal bleeding.Method:A total of 80 patients with liver cirrhosis complicated with upper gastrointestinal bleeding who treated in Nanjing First Hospital,Nanjing Medical University from August 2022 to October 2023 were selected as the research objects,they were divided into the control group(routine ward management)and the observation group(clinical pathway management model on the basis of control group)according to the random number table method,40 cases in each group.The nursing effect,psychological state,quality of life and treatment compliance were compared between two groups.Result:The hemostasis time and hospitalization time of the observation group were shorter than those of the control group,and the differences were statistically significant(P<0.05);the self-rating anxiety scale(SAS)scores and self-rating depression scale(SDS)score in the observation group after nursing were lower than those in the control group,and the scores of the MOS item short form health survey(SF-36)were higher than those in the control group,the differences were statistically significant(P<0.05);the total treatment compliance of the observation group was 95.0%,which was higher than 77.5%of the control group,and the difference was statistically significant(P<0.05).Conclusion:Clinical pathway management model can shorten the hemostasis and hospitalization time of patients with liver cirrhosis complicated with upper gastrointestinal bleeding,which is conducive to the improvement of negative mood,treatment compliance and quality of life.